We are monitoring the impact of COVID-19 on APAC Migraine Drug Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3953
Share on
Share on

Asia-Pacific Migraine Drug Market Research Report - Segmented By Treatment, By Therapeutic Class & By Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC)- Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: February, 2020
ID: 3953
Pages: 148

APAC Migraine Drug Market Size & Growth (2019 – 2024)

As per the research report, the size of the Asia-pacific Migraine Drug Market is valued at USD 0.72 billion in 2019 and estimated to be growing at a CAGR of 5.51%, to reach USD 0.95 billion by 2024 during the forecast period 2019-2024.

The chronic daily headache (CDH) prevalence in Asia might be lower when compared to global average. However, Data collected based on population for Chronic Migraine (CM) remains low and there are many variations in classification.

Asia-Pacific Migraine Drug Market is increasing at a slow rate due to growth in generalization of drugs. Market is witnessing huge number of unmet needs because of no permanent cure for disease. This attracted investors to make huge investments in R&D. Companies which manufacture and sell drugs which show efficacy profile and high safety are estimated to be competitive to their peers.

The growing requirement for new treatment choices has driven to the improvement of new devices, for example, antimigraine devices and headbands in the market. For example, Cefaly Transcutaneous Electrical Nerve Stimulation devices is a FDA affirmed devices for headache treatment. This device animates the trigeminal nerve by emanating electric streams and gives reduction from headache. Expanding spending in new research exercises and novel item advancements are relied upon to quicken the development and improvement of this market throughout the following four years.

This research report segmented and sub-segmented into the following categories:

  • By Treatment: Preventive And Absorptive
  • By Therapeutic Class: triptants, Ergots And Others
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

The Top companies leading in the APAC Migraine Drug Market profiled in the report are Allergan, GlaxoSmithKline, Pfizer, Endo, Impax Laboratories.The other prominent vendors the market include AbbottAeriel BioPharma, Alder Biopharmaceuticals, Amgen, Astellas, Bayer, CoLucid, Eli Lilly, IntelGenx, Ethypharm,Johnson & Johnson, Kowa Pharmaceuticals America, Klaria, Luitpold Pharmaceuticals, AstraZeneca, Meda, Dr. Reddy's Laboratories,  OptiNose, Pfizer, Pozen, Eisai, Raptor, RedHill, SUDA, Teva, , Aegis Therapeutics, Merck, TG Therapeutics, NValeant, Winston Pharmaceuticals, Allergan,  and Zogenix.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Preventive              

                                5.1.3 Abortive   

                                5.1.4  Y-o-Y Growth Analysis, By Treatment         

                                5.1.5  Market Attractiveness Analysis, By Treatment       

                                5.1.6  Market Share Analysis, By Treatment        

                5.2 Therapeutic                

                                5.2.1 Introduction           

                                5.2.2 Triptents  

                                5.2.3 Ergots        

                                5.2.4 Others      

                                5.2.5 Y-o-Y Growth Analysis, By Therapeutic       

                                5.2.6 Market Attractiveness Analysis, By Therapeutic     

                                5.2.7 Market Share Analysis, By Therapeutic       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By Therapeutic

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By Therapeutic

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By Therapeutic

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Allergan                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Endo International                  

                8.3  GlaxoSmithKline                      

                8.4 Impax                           

                8.5 Pfizer                            

                8.6 Aegis Therapeutics                  

                8.7 Alder Biopharmaceuticals                     

                8.8 Astellas                        

                8.9 AstraZeneca                               

                8.10 Aeriel BioPharma                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in daetail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environmentGlobal Medical Aesthetics Devices Market, Medical Aesthetics Devices Market research report, Medical Aesthetics Devices industry analysis
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Migraine Drug Market By Treatment, From 2019-2024 ( USD Billion )
  2. Asia-Pacific Preventive Market By Region, From 2019-2024 ( USD Billion )
  3. Asia-Pacific abortive Market By Region, From 2019-2024 ( USD Billion )
  4. Asia-Pacific Migraine Drug Market By Therapeutic, From 2019-2024 ( USD Billion )
  5. Asia-Pacific Triptents Market By Region, From 2019-2024 ( USD Billion )
  6. Asia-Pacific Ergots Market By Region, From 2019-2024 ( USD Billion )
  7. Asia-Pacific Others Market By Region, From 2019-2024 ( USD Billion )
  8. Japan Migraine Drug Market By Treatment, From 2019-2024 ( USD Billion )
  9. Japan Migraine Drug Market By Therapeutic, From 2019-2024 ( USD Billion )
  10. China Migraine Drug Market By Treatment, From 2019-2024 ( USD Billion )
  11. China Migraine Drug Market By Therapeutic, From 2019-2024 ( USD Billion )
  12. India Migraine Drug Market By Treatment, From 2019-2024 ( USD Billion )
  13. India Migraine Drug Market By Therapeutic, From 2019-2024 ( USD Billion )
  14. Australia Migraine Drug Market By Treatment, From 2019-2024 ( USD Billion )
  15. Australia Migraine Drug Market By Therapeutic, From 2019-2024 ( USD Billion )
  16. South Korea Migraine Drug Market By Treatment, From 2019-2024 ( USD Billion )
  17. South Korea Migraine Drug Market By Therapeutic, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample